AbbVie Inc

NYSE : ABBV

Industry : Pharmaceuticals | ISIN : US00287Y1091 | FreeFloat : 99.38% | FnO : Yes | LotSize : 100


Intellectual Capital (IC)385,764.20
Net Worth (NW)15,289.00
Intrinsic Worth (IW)401,053.20
Market Cap (MC)155,384.70
Economic Value Added1,939.74
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)96.19%
IC Gross Margin (EBITDA/IC)3.82%
IC Net Margin (NPT/IC)1.79%
Knowledge Turnover (Sales/IC)0.11
Market to Intrinsic Value (MC/IW)0.39

As OfIntrinsic ValueMarket Price
Sep 30 2020$ 226.07$ 87.59
Dec 3 2020 - $ 104.74
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : $ 102.79ReduceBuy on Dips
KB > 50% : Yes50 DMA : $ 91.37
0 < M2IV < 1 : YesVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results ($ Mn)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-17
C
7739.00
7739.00
2325.00
2013.00
1193.00
52.00
52.00
Mar-18
C
7934.00
8079.00
3551.00
3106.00
2797.00
2783.00
2783.00
Jun-18
C
8278.00
7800.00
2775.00
2332.00
2012.00
1983.00
1983.00
Sep-18
C
8236.00
8140.00
3535.00
3100.00
2761.00
2747.00
2747.00
Dec-18
C
8305.00
8692.00
-1551.00
-1993.00
-2373.00
-1826.00
-1826.00
Mar-19
C
7828.00
7687.00
3434.00
2931.00
2544.00
2456.00
2456.00
Jun-19
C
8255.00
5971.00
1667.00
1165.00
807.00
741.00
741.00
Sep-19
C
8479.00
8283.00
2984.00
2481.00
2001.00
1884.00
1884.00
Dec-19
C
8704.00
8138.00
4142.00
3633.00
3074.00
2801.00
2801.00
Mar-20
C
8619.00
8542.00
4220.00
3661.00
3098.00
3010.00
3010.00
Jun-20
C
10425.00
9594.00
1494.00
-61.00
-693.00
-738.00
-737.00
Sep-20
C
12902.00
12767.00
5422.00
3130.00
2500.00
2313.00
2308.00
* C - Consolidated, S - Standalone